Your session is about to expire
← Back to Search
PRT811 for Brain Tumor
Study Summary
This trial is testing a new cancer drug to see if it is safe and what the best dose is.
- Brain Tumor
- Solid Tumors
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are being accepted into this medical research?
"Indeed, clinicaltrials.gov provides evidence that this medical trial is actively looking for participants. It was initially posted on November 6th 2019 and the most recent modifications were made on November 28th 2022. The investigation requires 145 subjects across 10 centres to be enrolled ."
Where are the available facilities for participating in this clinical investigation?
"10 clinical trial sites are currently accepting patients for the study. In addition to New Haven, Saint Louis and Augusta, there are 7 other locations available. To minimise travel costs, it is advisable to select a clinic located nearby when enrolling in this trial."
Is enrollment still available for this research endeavor?
"Affirmative. The details available on clinicaltrials.gov reveal that this investigation is presently searching for participants, having been initially posted on November 6th 2019 and most recently edited on the 28th of November 2022. A total of 145 patients from 10 medical centres must be enrolled to complete the trial."
Has the FDA sanctioned PRT811 for public consumption?
"PRT811's safety score is a 1 because of the limited clinical data that supports its efficacy and safety."
Share this study with friends
Copy Link
Messenger